Overexpression of COX-2 has been reported in several cancers, such as colorectal [12, 13], pancreatic [14], breast [15], esophageal [16], gastric [17], lung [18, 19], and several other cancers [20–23]. This evidence concerns the gene PTGS2 and cancer.